Topic: AS08-Treatment/AS08e-New developments - Preclinical studies: IGF-1R ACTIVATION SECONDARY TO HAPLOINSUFFICIENCY OF MIR-143 AND MIR-145 IS A TARGETABLE DEPENDENCY OF DEL(5Q) MDS. (September 2021)